Stocks and Investing Stocks and Investing
Fri, September 4, 2015
Thu, September 3, 2015
Wed, September 2, 2015
Tue, September 1, 2015
Mon, August 31, 2015

Paul Matteis Maintained (ALNY) at Buy with Increased Target to $151 on, Aug 31st, 2015


Published on 2024-10-25 09:51:41 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $145 to $151 on, Aug 31st, 2015.

Paul has made no other calls on ALNY in the last 4 months.



There are 3 other peers that have a rating on ALNY. Out of the 3 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Maintained at Hold with Decreased Target to $115 on, Friday, August 7th, 2015


These are the ratings of the 2 analyists that currently disagree with Paul


  • Rahul Jasuja of "FBR Capital" Initiated at Buy and Held Target at $180 on, Tuesday, August 11th, 2015
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $180 on, Monday, June 15th, 2015
Contributing Sources